Benefits |
---|
Breast cancer mortality reduction |
Relative risk reduction |
Absolute risk reduction |
Survival time from diagnosis |
Number needed to screen |
Carcinoma in situ, as positive |
Less mastectomies/more tumourectomies |
Total mortality reduction |
Other |
Harms |
Overdiagnosis and overtreatment |
Recall rate: |
1. Per screen |
2. Cumulative |
More mastectomies/more tumourectomies |
Increased biopsy rate |
Risks associated with additional radiotherapy |
Psychological effects related to false positives |
Carcinoma in situ, as negative |
Pain at mammography |
Other |